Insmed Inc $ 29.51 2.73 (10.19%)
Volume:
1,679,736
Avg Vol (1m):
843,607
Market Cap $:
2.98 Bil
Enterprise Value $:
2.95 Bil
P/E (TTM):
0.00
P/B:
12.80
Financial Strength | 3/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 1.08 | ||
| Equity-to-Asset | 0.31 | ||
| Debt-to-Equity | 1.93 | ||
| Debt-to-EBITDA | -1.93 | ||
| Piotroski F-Score | 5 | ||
| Altman Z-Score | 0.04 | ||
| Beneish M-Score | 0.29 | ||
| WACC vs ROIC | |||
Profitability Rank | 1/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | -149.31 | ||
| Net Margin % | -162.82 | ||
| ROE % | -96.83 | ||
| ROA % | -34.43 | ||
| ROC (Joel Greenblatt) % | -231.38 | ||
| 3-Year EBITDA Growth Rate | 2.3 | ||
| 3-Year EPS without NRI Growth Rate | -1.8 |
Valuation Rank |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PB Ratio | 12.8 | ||
| PS Ratio | 17.12 | ||
| EV-to-EBIT | -13.47 | ||
| EV-to-EBITDA | -14.3 | ||
| EV-to-Revenue | 19.51 | ||
| Current Ratio | 6.89 | ||
| Quick Ratio | 6.46 | ||
| Days Inventory | 294.85 | ||
| Days Sales Outstanding | 41.35 | ||
| Days Payable | 232.93 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -13.1 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Tangible-Book | 17.16 | ||
| Earnings Yield (Greenblatt) % | -7.41 |